BackCorcept Therapeutics Overview
Corcept Therapeutics Inc

Corcept Therapeutics Target Price

Analysts' 12-month price predictions for CORT.

Get informed when a big investor buys or sells

+ Follow

Share Price

$79.85

Average Target Price

$93.0016.5% upside

5 analysts in the last 4 months

High: $135 | Low: $72

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-02H.C. WainwrightSwayampakula Ramakanth$9519% upsideOpen
2026-05-28UBS$13569.1% upsideOpen
2026-05-13UBS$729.8% downsideOpen
2026-05-04H.C. Wainwright$756.1% downsideOpen
2026-05-01Piper Sandler$8810.2% upsideOpen
2026-02-20H.C. Wainwright$6716.1% downsideOpen
2026-01-23Canaccord Genuity$10025.2% upsideOpen
2026-01-22H.C. WainwrightSwayampakula Ramakanth$10531.5% upsideOpen
2026-01-02H.C. WainwrightSwayampakula Ramakanth$9012.7% upsideOpen
2026-01-02Canaccord GenuityEdward Nash$9924% upsideOpen
2025-12-31Truist Financial$5037.4% downsideOpen
2025-12-31Wolfe Research$3062.4% downsideOpen
2025-12-16UBSAshwani Verma$9519% upsideOpen
2025-09-10Canaccord Genuity$14075.3% upsideOpen
2025-05-06Truist FinancialJoon Lee$13569.1% upsideOpen
2025-05-06H.C. WainwrightSwayampakula Ramakanth$14581.6% upsideOpen
2024-10-18H.C. WainwrightSwayampakula Ramakanth$800.2% upsideOpen
2024-09-30Truist FinancialJoon Lee$764.8% downsideOpen
2024-08-15Canaccord GenuityEdward Nash$782.3% downsideOpen
2024-07-30Piper SandlerDavid Amsellem$3852.4% downsideOpen
2024-07-30H.C. WainwrightSwayampakula Ramakanth$4543.6% downsideOpen
2024-06-12Canaccord GenuityEdward Nash$3852.4% downsideOpen
2024-06-10Piper SandlerDavid Amsellem$3556.2% downsideOpen
2024-06-04Truist FinancialJoon Lee$6518.6% downsideOpen
2024-05-02H.C. WainwrightSwayampakula Ramakanth$4049.9% downsideOpen
2022-12-09H.C. Wainwright$3062.4% downsideOpen
2022-08-04H.C. Wainwright$3358.7% downsideOpen